CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors

References

• Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 1993; 12:469-78; PMID:8440238
   PubMed Web of Science ®Google Scholar
• Schaeper U, Subramanian T, Lim L, Boyd JM, Chinnadurai G. Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem 1998; 273:8549-52; PMID:9535825; https://doi.org/10.1074/jbc.273.15.8549
   PubMed Web of Science ®Google Scholar
• Chinnadurai G, Chinnadurai G. CtBP family proteins: Unique transcriptional regulators in the nucleus with diverse cytosolic functions. In: Madame Curie Bioscience Database. Austin (TX): Landes Bioscience; 2000–2013; https://doi.org/10.1007/978-0-387-39973-7_1
   Google Scholar
• Hildebrand JD, Soriano P. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol Cell Biol 2002; 22:5296-307; PMID:12101226; https://doi.org/10.1128/MCB.22.15.5296-5307.2002
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. CtBP family proteins. In: Chinnadurai G, ed. GtBP Family Proteins. New York, NY: Springer New York; 2007:1-17; https://doi.org/10.1007/978-0-387-39973-7_1
   Google Scholar
• Nibu Y, Zhang H, Bajor E, Barolo S, Small S, Levine M. dCtBP mediates transcriptional repression by knirps, kruppel and snail in the drosophila embryo. EMBO J 1998; 17:7009-7020; PMID:9843507; https://doi.org/10.1093/emboj/17.23.7009
   PubMed Web of Science ®Google Scholar
• Nibu Y, Zhang H, Levine M. Interaction of short-range repressors with drosophila CtBP in the embryo. Science 1998; 280:101-4; PMID:9525852; https://doi.org/10.1126/science.280.5360.101
   PubMed Web of Science ®Google Scholar
• Poortinga G, Watanabe M, Parkhurst SM. Drosophila CtBP: A hairy-interacting protein required for embryonic segmentation and hairy-mediated transcriptional repression. EMBO J 1998; 17:2067-78; PMID:9524128; https://doi.org/10.1093/emboj/17.7.2067
   PubMed Web of Science ®Google Scholar
• Reid A, Yucel D, Wood M, Llamosas E, Kant S, Crossley M, Nicholas H. The transcriptional repressor CTBP-1 functions in the nervous system of caenorhabditis elegans to regulate lifespan. Exp Gerontol 2014; 60:153-65; PMID:25456848; https://doi.org/10.1016/j.exger.2014.09.022
   PubMed Web of Science ®Google Scholar
• Chen S, Whetstine JR, Ghosh S, Hanover JA, Gali RR, Grosu P, Shi Y. The conserved NAD(H)-dependent corepressor CTBP-1 regulates caenorhabditis elegans life span. Proc Nat Acad Sci 2009; 106:1496-501; PMID:19164523; https://doi.org/10.1073/pnas.0802674106
   PubMed Web of Science ®Google Scholar
• Stankiewicz TR, Gray JJ, Winter AN, Linseman DA. C-terminal binding proteins: Central players in development and disease. Biomol Concepts 2014; 5:489-511; PMID:25429601; https://doi.org/10.1515/bmc-2014-0027
   PubMedGoogle Scholar
• Garriga-Canut M, Schoenike B, Qazi R, Bergendahl K, Daley TJ, Pfender RM, Morrison JF, Ockuly J, Stafstrom C, Sutula T, Roopra A. 2-deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci 2006; 9:1382-87; PMID:17041593; https://doi.org/10.1038/nn1791
   PubMed Web of Science ®Google Scholar
• Saijo K, Collier JG, Li AC, Katzenellenbogen JA, Glass CK. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 2011; 145:584-95; PMID:21565615; https://doi.org/10.1016/j.cell.2011.03.050
   PubMed Web of Science ®Google Scholar
• Huard CC, Tremblay CS, Helsper K, Delisle MC, Schindler D, Levesque G, Carreau M. Fanconi anemia proteins interact with CtBP1 and modulate the expression of the wnt antagonist dickkopf-1. Blood 2013; 121:1729-39; PMID:23303816; https://doi.org/10.1182/blood-2012-02-408997
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. The transcriptional corepressor CtBP: A foe of multiple tumor suppressors. Cancer Res 2009; 69:731-4; PMID:19155295; https://doi.org/10.1158/0008-5472.CAN-08-3349
   PubMed Web of Science ®Google Scholar
• Bergman LM, Morris L, Darley M, Mirnezami AH, Gunatilake SC, Blaydes JP. Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins. BMC Cell Biol 2006; 7:35; PMID:16999872; https://doi.org/10.1186/1471-2121-7-35
   PubMed Web of Science ®Google Scholar
• Lundblad JR. Structural determinants of CtBP function. In: Chinnadurai G, ed. GtBP Family Proteins. New York, NY: Springer New York; 2007:83-92; https://doi.org/10.1007/978-0-387-39973-7_1
   Google Scholar
• Kuppuswamy M, Vijayalingam S, Zhao LJ, Zhou Y, Subramanian T, Ryerse J, Chinnadurai G. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol 2008; 28:269-81; PMID:17967884; https://doi.org/10.1128/MCB.01077-07
   PubMed Web of Science ®Google Scholar
• Verger A, Quinlan KG, Crofts LA, Spano S, Corda D, Kable EP, Braet F, Crossley M. Mechanisms directing the nuclear localization of the CtBP family proteins. Mol Cell Biol 2006; 26:4882-94; PMID:16782877; https://doi.org/10.1128/MCB.02402-05
   PubMed Web of Science ®Google Scholar
• Corda D, Colanzi A, Luini A. The multiple activities of CtBP/BARS proteins: The golgi view. Trends Cell Biol 2006; 16:167-73; PMID:16483777; https://doi.org/10.1016/j.tcb.2006.01.007
   PubMed Web of Science ®Google Scholar
• Bartz R, Seemann J, Zehmer JK, Serrero G, Chapman KD, Anderson RG, Liu P. Evidence that mono-ADP-ribosylation of CtBP1/BARS regulates lipid storage. Mol Biol Cell 2007; 18:3015-25; PMID:17538025; https://doi.org/10.1091/mbc.E06-09-0869
   PubMed Web of Science ®Google Scholar
• Schmitz F, Konigstorfer A, Sudhof TC. RIBEYE, a component of synaptic ribbons: A protein's journey through evolution provides insight into synaptic ribbon function. Neuron 2000; 28:857-72; PMID:11163272; https://doi.org/10.1016/S0896-6273(00)00159-8
   PubMed Web of Science ®Google Scholar
• Shi Y, Sawada J, Sui G, Affar el B, Whetstine JR, Lan F, Ogawa H, Luke MP, Nakatani Y, Shi Y. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003; 422:735-8; PMID:12700765; https://doi.org/10.1038/nature01550
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. CtBP family proteins: More than transcriptional corepressors. Bioessays 2003; 25:9-12; PMID:12508276; https://doi.org/10.1002/bies.10212
   PubMed Web of Science ®Google Scholar
• Quinlan KG, Verger A, Kwok A, Lee SH, Perdomo J, Nardini M, Bolognesi M, Crossley M. Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression. Mol Cell Biol 2006; 26:8202-13; PMID:16940173; https://doi.org/10.1128/MCB.00445-06
   PubMed Web of Science ®Google Scholar
• Zhang CL, McKinsey TA, Lu J, Olson EN. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem 2001; 276:35-9; PMID:11022042; https://doi.org/10.1074/jbc.M007364200
   PubMed Web of Science ®Google Scholar
• Vliet Jv, Turner J, Crossley M. Human krüppel-like factor 8: A CACCC-box binding protein that associates with CtBP and represses transcription. Nucleic Acids Res 2000; 28:1955-62; PMID:10756197; https://doi.org/10.1093/nar/28.9.1955
   PubMed Web of Science ®Google Scholar
• Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005; 19:857-64; PMID:16140033; https://doi.org/10.1016/j.molcel.2005.08.027
   PubMed Web of Science ®Google Scholar
• Ray SK, Li HJ, Metzger E, Schüle R, Leiter AB. CtBP and associated LSD1 are required for transcriptional activation by NeuroD1 in gastrointestinal endocrine cells. Mol Cell Biol 2014; 34:2308-17; PMID:24732800; https://doi.org/10.1128/MCB.01600-13
   PubMed Web of Science ®Google Scholar
• Kumar V, Carlson JE, Ohgi KA, Edwards TA, Rose DW, Escalante CR, Rosenfeld MG, Aggarwal AK. Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase. Mol Cell 2002; 10:857-869; PMID:12419229; https://doi.org/10.1016/S1097-2765(02)00650-0
   PubMed Web of Science ®Google Scholar
• Bhambhani C, Chang JL, Akey DL, Cadigan KM. The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of wingless targets. EMBO J 2011; 30:2031-43; PMID:21468031; https://doi.org/10.1038/emboj.2011.100
   PubMed Web of Science ®Google Scholar
• Fang M, Li J, Blauwkamp T, Bhambhani C, Campbell N, Cadigan KM. C-terminal-binding protein directly activates and represses wnt transcriptional targets in drosophila. EMBO J 2006; 25:2735-45; PMID:16710294; https://doi.org/10.1038/sj.emboj.7601153
   PubMed Web of Science ®Google Scholar
• Ray SK, Li HJ, Leiter AB. Oligomeric form of C-terminal-binding protein coactivates NeuroD1-mediated transcription. FEBS Lett 2017; 591:205-12; PMID:27880001; https://doi.org/10.1002/1873-3468.12501
   PubMed Web of Science ®Google Scholar
• Zhang Q, Piston DW, Goodman RH. Regulation of corepressor function by nuclear NADH. Science 2002; 295:1895-7; PMID:11847309; https://doi.org/10.1126/science.1069300
   PubMed Web of Science ®Google Scholar
• Madison DL, Wirz JA, Siess D, Lundblad JR. Nicotinamide adenine dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a switching tryptophan. J Biol Chem 2013; 288:27836-48; PMID:23940047; https://doi.org/10.1074/jbc.M113.493569
   PubMed Web of Science ®Google Scholar
• Kuppuswamy M, Vijayalingam S, Zhao L, Zhou Y, Subramanian T, Ryerse J, Chinnadurai G. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol 2008; 28:269-81; PMID:17967884; https://doi.org/10.1128/MCB.01077-07
   PubMed Web of Science ®Google Scholar
• Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci U S A 2003; 100:4568-73; PMID:12676992; https://doi.org/10.1073/pnas.0830998100
   PubMed Web of Science ®Google Scholar
• Barnes CJ, Vadlamudi RK, Mishra SK, Jacobson RH, Li F, Kumar R. Functional inactivation of a transcriptional corepressor by a signaling kinase. Nat Struct Mol Biol 2003; 10:622-8 PMID:12872159; https://doi.org/10.1038/nsb957
   PubMed Web of Science ®Google Scholar
• Kim J, Choi S, Kang B, Lee S, Park HS, Kang G, Bang JY, Cho E, Youn H. AMP-activated protein kinase phosphorylates CtBP1 and down-regulates its activity. Biochem Biophys Res Commun 2013; 431:8-13; PMID:23291169; https://doi.org/10.1016/j.bbrc.2012.12.117
   PubMed Web of Science ®Google Scholar
• Merrill JC, Kagey MH, Melhuish TA, Powers SE, Zerlanko BJ, Wotton D. Inhibition of CtBP1 activity by akt-mediated phosphorylation. J Mol Biol 2010; 398:657-71; PMID:20361981; https://doi.org/10.1016/j.jmb.2010.03.048
   PubMed Web of Science ®Google Scholar
• Nardini M, Svergun D, Konarev PV, Spano S, Fasano M, Bracco C, Pesce A, Donadini A, Cericola C, Secundo F, Luini A, Corda D, Bolognesi M. The C-terminal domain of the transcriptional corepressor CtBP is intrinsically unstructured. Protein Sci 2006; 15:1042-1050; PMID:16597837; https://doi.org/10.1110/ps.062115406
   PubMed Web of Science ®Google Scholar
• Riefler GM, Firestein BL. Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CtBP) changes the localization of CtBP from the nucleus to the cytosol: a novel function for targeting by the PDZ domain of nNOS. J Biol Chem 2001; 276:48262-8; PMID:11590170; https://doi.org/10.1074/jbc.M106503200
   PubMed Web of Science ®Google Scholar
• Lin X, Sun B, Liang M, Liang YY, Gast A, Hildebrand J, Brunicardi FC, Melchior F, Feng XH. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 2003; 11:1389-96; PMID:12769861; https://doi.org/10.1016/S1097-2765(03)00175-8
   PubMed Web of Science ®Google Scholar
• Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N, Grossman SR. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol 2006; 26:2360-72; PMID:16508011; https://doi.org/10.1128/MCB.26.6.2360-2372.2006
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 2003; 115:177-86; PMID:14567915; https://doi.org/10.1016/S0092-8674(03)00802-X
   PubMed Web of Science ®Google Scholar
• Wang S, Iordanov M, Zhang Q. C-jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. J Biol Chem 2006; 281:34810-15; PMID:16984892; https://doi.org/10.1074/jbc.M607484200
   PubMed Web of Science ®Google Scholar
• Hofmann TG, Stollberg N, Schmitz ML, Will H. HIPK2 regulates transforming growth factor-ß-induced c-jun NH2-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 2003; 63:8271-77; PMID:14678985
   PubMed Web of Science ®Google Scholar
• Yang SH, Galanis A, Witty J, Sharrocks AD. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 2006; 25:5083-93; PMID:17036045; https://doi.org/10.1038/sj.emboj.7601383
   PubMed Web of Science ®Google Scholar
• Kovi RC, Paliwal S, Pande S, Grossman SR. An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis. Cell Death Differ 2010; 17:513-21; PMID:19798104; https://doi.org/10.1038/cdd.2009.140
   PubMed Web of Science ®Google Scholar
• Paliwal S, Kovi RC, Nath B, Chen YW, Lewis BC, Grossman SR. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. Cancer Res 2007; 67:932229; PMID:17909040; https://doi.org/10.1158/0008-5472.CAN-07-1743
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 2002; 9:213-24; PMID:11864595; https://doi.org/10.1016/S1097-2765(02)00443-4
   PubMed Web of Science ®Google Scholar
• Lin HJ, Eviner V, Prendergast GC, White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 1995; 15:4536-44; PMID:7623844; https://doi.org/10.1128/MCB.15.8.4536
   PubMed Web of Science ®Google Scholar
• Palmer S, Brouillet J, Kilbey A, Fulton R, Walker M, Crossley M, Bartholomew C. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J Biol Chem 2001; 276:25834-40; PMID:11328817; https://doi.org/10.1074/jbc.M102343200
   PubMed Web of Science ®Google Scholar
• Sumner. ET, Chawla A, Cororaton A, Koblinski J, Kovi R, Love I, Szomju B, Korwar S, Ellis K, Grossman S. Transforming activity and therapeutic targeting of C-terminal binding protein 2 in apc mutated neoplasia. Oncogene 2017; in press; PMID:28414304; https://doi.org/10.1038/onc.2017.106
   PubMedGoogle Scholar
• Byun JS, Gardner K. C-terminal binding protein: A molecular link between metabolic imbalance and epigenetic regulation in breast cancer. Int J Cell Biol 2013; 2013:647975; PMID:23762064; https://doi.org/10.1155/2013/647975
   PubMedGoogle Scholar
• Zheng X, Song T, Dou C, Jia Y, Liu Q. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma. Oncotarget 2015; 6:3752-69; PMID:25686837; https://doi.org/10.18632/oncotarget.2915
   PubMed Web of Science ®Google Scholar
• Birts CN, Harding R, Soosaipillai G, Halder T, Azim-Araghi A, Darley M, Cutress RI, Bateman AC, Blaydes JP. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance. Biol Cell 2010; 103:1-19; PMID:20964627; https://doi.org/10.1042/BC20100067
   PubMed Web of Science ®Google Scholar
• Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, Baek S, Hunter K, Yang H, Lee M, Zvosec C, Khramtsova G, Cheng F, Perou CM, Miller CR, Raab R, Olopade OI, Gardner K. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun 2013; 4:1449; PMID:23385593; https://doi.org/10.1038/ncomms2438
   PubMed Web of Science ®Google Scholar
• Jin W, Scotto KW, Hait WN, Yang J. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Biochem Pharmacol 2007; 74:851-9; PMID:17662696; https://doi.org/10.1016/j.bcp.2007.06.017
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg R. Hallmarks of cancer: The next generation. Cell 2011; 144:646-74; PMID:21376230; https://doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Wang R, Asangani IA, Chakravarthi BV, Ateeq B, Lonigro RJ, Cao Q, Mani RS, Camacho DF, McGregor N, Schumann TE, Jing X, Menawat R, Tomlins SA, Zheng H, Otte AP, Mehra R, Siddiqui J, Dhanasekaran SM, Nyati MK, Pienta KJ, Palanisamy N, Kunju LP, Rubin MA, Chinnaiyan AM, Varambally S. Role of transcriptional corepressor CtBP1 in prostate cancer progression. Neoplasia 2012; 14:905-14; PMID:23097625; https://doi.org/10.1593/neo.121192
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-28; PMID:19487818; https://doi.org/10.1172/JCI39104
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang SY, Nottke AC, Rocheleau JV, Piston DW, Goodman RH. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci U S A 2006; 103:9029-33; PMID:16740659; https://doi.org/10.1073/pnas.0603269103
   PubMed Web of Science ®Google Scholar
• Zhang XL, Huang CX, Zhang J, Inoue A, Zeng SE, Xiao SJ. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma. Oncol Rep 2013; 30:809-14; PMID:23756565; https://doi.org/10.3892/or.2013.2537
   PubMed Web of Science ®Google Scholar
• Shin S, Dimitri CA, Yoon S, Dowdle W, Blenis J. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 2010; 38:114-127; PMID:20385094; https://doi.org/10.1016/j.molcel.2010.02.020
   PubMed Web of Science ®Google Scholar
• Ichikawa K, Kubota Y, Nakamura T, Weng J, Tomida T, Saito H, Takekawa M. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP. Mol Cell 2015; 58:35-46; PMID:25728771; https://doi.org/10.1016/j.molcel.2015.01.023
   PubMed Web of Science ®Google Scholar
• Barroilhet L, Yang J, Hasselblatt K, Paranal RM, Ng SK, Rauh-Hain JA, Welch WR, Bradner JE, Berkowitz RS, Ng SW. C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene 2013; 32:3896-903; PMID:22945647; https://doi.org/10.1038/onc.2012.380
   PubMed Web of Science ®Google Scholar
• Minard ME, Kim LS, Price JE, Gallick GE. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 2004; 84:21-32; PMID:14999151; https://doi.org/10.1023/B:BREA.0000018421.31632.e6
   PubMed Web of Science ®Google Scholar
• Yamada KM, Araki M. Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001; 114:2375-82; PMID:11559746
   PubMed Web of Science ®Google Scholar
• Paliwal S, Ho N, Parker D, Grossman SR. CtBP2 promotes human cancer cell migration by transcriptional activation of Tiam1. Genes Cancer 2012; 3:481-90; PMID:23264848; https://doi.org/10.1177/1947601912463695
   PubMedGoogle Scholar
• Di L, Fernandez AG, De Siervi A, Longo DL, Gardner K. Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol 2010; 17:1406-13; PMID:21102443; https://doi.org/10.1038/nsmb.1941
   PubMed Web of Science ®Google Scholar
• Moiola CP, De Luca P, Zalazar F, Cotignola J, Rodriguez-Segui SA, Gardner K, Meiss R, Vallecorsa P, Pignataro O, Mazza O, Vazquez ES, De Siervi A. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice. Clin Cancer Res 2014; 20:4086-95; PMID:24842953; https://doi.org/10.1158/1078-0432.CCR-14-0322
   PubMed Web of Science ®Google Scholar
• De Luca P, Dalton GN, Scalise GD, Moiola CP, Porretti J, Massillo C, Kordon E, Gardner K, Zalazar F, Flumian C, et al. CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs. Oncotarget 2016; 7(14):18798-811; PMID:26933806; https://doi.org/10.18632/oncotarget.7711
   PubMed Web of Science ®Google Scholar
• Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013; 13:11-26; PMID:23258168; https://doi.org/10.1038/nrc3419
   PubMed Web of Science ®Google Scholar
• Hamada F, Bienz M. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev Cell 2004; 7:677-85; PMID:15525529; https://doi.org/10.1016/j.devcel.2004.08.022
   PubMed Web of Science ®Google Scholar
• Schneikert J, Brauburger K, Behrens J. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC. Human Mol Genet 2011; 20:3554-64; PMID:21665989; https://doi.org/10.1093/hmg/ddr273
   PubMed Web of Science ®Google Scholar
• Choi SH, Estaras C, Moresco JJ, Yates JR, Jones KA 3rd. Alpha-catenin interacts with APC to regulate beta-catenin proteolysis and transcriptional repression of wnt target genes. Genes Dev 2013; 27:2473-88; PMID:24240237; https://doi.org/10.1101/gad.229062.113
   PubMed Web of Science ®Google Scholar
• Sierra J, Yoshida T, Joazeiro CA, Jones KA. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at wnt target genes. Genes Dev 2006; 20:586-600; PMID:16510874; https://doi.org/10.1101/gad.1385806
   PubMed Web of Science ®Google Scholar
• Patel J, Baranwal S, Love IM, Patel NJ, Grossman SR, Patel BB. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells. Cell Cycle 2014; 13:3506-18; PMID:25483087; https://doi.org/10.4161/15384101.2014.958407
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100:3983-88; PMID:12629218; https://doi.org/10.1073/pnas.0530291100
   PubMed Web of Science ®Google Scholar
• Achouri Y, Noël G, Van Schaftingen E. 2-keto-4-methylthiobutyrate, an intermediate in the methionine salvage pathway, is a good substrate for CtBP1. Biochem Biophys Res Commun 2007; 352:903-6; PMID:17157814; https://doi.org/10.1016/j.bbrc.2006.11.111
   PubMed Web of Science ®Google Scholar
• Hilbert BJ, Morris BL, Ellis KC, Paulsen JL, Schiffer CA, Grossman SR, Royer WE, Jr. Structure-guided design of a high affinity inhibitor to human CtBP. ACS Chem Biol 2015; 10:1118-1127; PMID:25636004; https://doi.org/10.1021/cb500820b
   PubMed Web of Science ®Google Scholar
• Sauter M, Moffatt B, Saechao MC, Hell R, Wirtz M. Methionine salvage and S-adenosylmethionine: Essential links between sulfur, ethylene and polyamine biosynthesis. Biochem J 2013; 451:145-54; PMID:23535167; https://doi.org/10.1042/BJ20121744
   PubMed Web of Science ®Google Scholar
• Tang B, Kadariya Y, Murphy ME, Kruger WD. The methionine salvage pathway compound 4-methylthio-2-oxobutanate causes apoptosis independent of down-regulation of ornithine decarboxylase. Biochem Pharmacol 2006; 72:806-15; PMID:16870157; https://doi.org/10.1016/j.bcp.2006.06.018
   PubMed Web of Science ®Google Scholar
• Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-myc. Proc Nat Acad Sci 1993; 90:7804-08; PMID:8356088; https://doi.org/10.1073/pnas.90.16.7804
   PubMed Web of Science ®Google Scholar
• Straza MW, Paliwal S, Koi RC, Rajeshkumar B, Trenh P, Parker D, Whalen GF, Lyle S, Schiffer CA, Grossman SR. Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 2010; 9:3740-50; PMID:20930544; https://doi.org/10.4161/cc.9.18.12936
   PubMed Web of Science ®Google Scholar
• Li M, Riddle S, Zhang H, D'Alessandro A, Flockton A, Serkova NJ, Hansen KC, Moldvan R, McKeon BA, Frid M, et al. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-terminal binding protein-1. Circulation 2016; 134:1105-21; PMID:27562971; https://doi.org/10.1161/CIRCULATIONAHA.116.023171
   PubMed Web of Science ®Google Scholar
• Hilbert BJ, Grossman SR, Schiffer CA, Royer WE, Jr. Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design. FEBS Lett 2014; 588:1743-48; PMID:24657618; https://doi.org/10.1016/j.febslet.2014.03.026
   PubMed Web of Science ®Google Scholar
• Korwar S, Morris BL, Parikh HI, Coover RA, Doughty TW, Love IM, Hilbert BJ, Royer Jr. WE, Kellogg GE, Grossman SR, Ellis KC. Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal binding protein (CtBP). Bioorg Med Chem 2016; 24:2707-15; PMID:27156192; https://doi.org/10.1016/j.bmc.2016.04.037
   PubMed Web of Science ®Google Scholar
• Alvarez JA, Gelpí JL, Johnsen K, Bernard N, Delcour J, Clarke AR, Holbrook JJ, Cortés A. D-2-hydroxy-4-methylvalerate dehydrogenase from lactobacillus delbrueckii subsp. bulgaricus? I. kinetic mechanism and pH dependence of kinetic parameters, coenzyme binding and substrate inhibition. Eur J Biochem 1997; 244:203-12; PMID:9063465; https://doi.org/10.1111/j.1432-1033.1997.00203.x
   PubMedGoogle Scholar
• Gao M, Cheng K, Yin H. Targeting protein-protein interfaces using macrocyclic peptides. Biopolymers 2015; 104:310-6; PMID:25664609; https://doi.org/10.1002/bip.22625
   PubMed Web of Science ®Google Scholar
• Birts CN, Nijjar SK, Mardle CA, Hoakwie F, Duriez PJ, Blaydes JP, Tavassoli A. A cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cells. Chem Sci 2013; 4:3046-57; https://doi.org/10.1039/c3sc50481f
   PubMed Web of Science ®Google Scholar
• Blevins MA, Kouznetsova J, Krueger AB, King R, Griner LM, Hu X, Southall N, Marugan JJ, Zhang Q, Ferrer M, Zhao R. Small molecule, NSC95397, inhibits the CtBP1-protein partner interaction and CtBP1-mediated transcriptional repression. J Biomol Screen 2015; 20:663-672; PMID:25477201; https://doi.org/10.1177/1087057114561400
   PubMedGoogle Scholar
• Yang Y, Yang WS, Yu T, Yi Y, Park JG, Jeong D, Kim JH, Oh JS, Yoon K, Kim J, Cho JY. Novel anti-inflammatory function of NSC95397 by the suppression of multiple kinases. Biochem Pharmacol 2014; 88:201-15; PMID:24468133; https://doi.org/10.1016/j.bcp.2014.01.022
   PubMed Web of Science ®Google Scholar
• Dulyaninova NG, Hite KM, Zencheck WD, Scudiero DA, Almo SC, Shoemaker RH, Bresnick AR. Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA. Biochemistry 2011; 50:7218-27; PMID:21749055; https://doi.org/10.1021/bi200853y
   PubMed Web of Science ®Google Scholar
• Larsson DE, Wickstrom M, Hassan S, Oberg K, Granberg D. The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro. Anticancer Res 2010; 30:149-56; PMID:20150630
   PubMed Web of Science ®Google Scholar
• Vogt A, McDonald PR, Tamewitz A, Sikorski RP, Wipf P, Skoko JJ, Lazo JS 3rd. A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells. Mol Cancer Ther 2008; 7:330-40; PMID:18245669; https://doi.org/10.1158/1535-7163.MCT-07-2165
   PubMed Web of Science ®Google Scholar
• Zhang C, Gao C, Xu Y, Zhang Z. CtBP2 could promote prostate cancer cell proliferation through c-myc signaling. Gene 2014; 546:73-9; PMID:24835310; https://doi.org/10.1016/j.gene.2014.05.032
   PubMed Web of Science ®Google Scholar
• Liu B, Di G. C-terminal binding protein is involved in promoting to the carcinogenesis of human glioma. Mol Neurobiol 2016; PMID:27699603; https://doi.org/10.1007/s12035-016-0159-x
   PubMed Web of Science ®Google Scholar